Itau Unibanco Holding S.A. Avidity Biosciences, Inc. Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$22.73 - $40.85 $9,682 - $17,402	426 New	426 $17,000
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $3,136 - $6,034	644 Added 27.83%	2,958 $26,000
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $3,584 - $6,458	569 Added 32.61%	2,314 $14,000
Q2 2023 Aug 14, 2023	SELL	$10.62 - $17.34 $1,688 - $2,757	-159 Reduced 8.35%	1,745 $19,000
Q1 2023 May 12, 2023	SELL	$15.35 - $25.65 $92 - $153	-6 Reduced 0.31%	1,904 $29,000
Q4 2022 Feb 09, 2023	BUY	$10.06 - $22.66 $2,997 - $6,752	298 Added 18.49%	1,910 $42,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $24,921 - $37,769	1,612 New	1,612 $26,000

250

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.7B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.